SEATTLE, WA, May 29, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that Robert Kirkman, M.D., President and Chief
Executive Officer, will be presenting at the Jefferies 2012 Global
Healthcare Conference in New York on Tuesday, June 5, 2012 at 4:00 p.m.
A live and archived webcast of the presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.